Health & Environmental Research Online (HERO)


Print Feedback Export to File
7436897 
Journal Article 
Breast Cancer Risk and Screening in Transgender Individuals 
Roznovjak, D; Petroll, A; Cortina, CS; , 
2021 
56-61 
There are over 1.4 million individuals who identify as transgender in the USA, and these individuals are frequently treated with cross-sex hormonal therapy (CSH) to acquire their desired phenotype. Simultaneously, breast cancer is one of the most common cancers in the USA, and there are mixed data on how CSH may influence breast cancer development in transgender individuals. Here, we review the barriers that exist to health access in this population, the current evidence of breast cancer risk in transgender individuals, and breast cancer screening guidelines for both transgender women and men.